猪IL-15与PRRSV ORF5基因真核表达质粒的构建及其免疫原性分析
|
摘要
本实验分别将(猪繁殖与呼吸综合征病毒)PRRSV ORF5基因与猪IL-15基因亚克隆至pVAX1真核表达载体中,构建了两个重组真核表达质粒pVAX1-PRRSV ORF5和pVAX1-pIL-15。通过脂质体转染法将pVAX1-PRRSV ORF5和pVAX1-pIL-15转入Vero细胞中进行了表达,试验结果表明,两个基因都可以在体外进行表达,且表达的蛋白可以被PRRSV ORF5和pIL-15多克隆抗体所检测。以pVAX1-PRRSV ORF5和pVAX1-pIL-15重组真核表达质粒免疫小鼠,分为7个组,分别是pVAX1-PRRSV ORF5单独免疫组、pVAX1-pIL-15单独免疫组、pVAX1-PRRSV ORF5(100μg)与pVAX1-pIL-15(100μg)联合免疫组、pVAX1-PRRSV ORF5(100μg)与pVAX1-pIL-15(200μg)联合免疫组、pVAX1-PRRSV ORF5(100μg)与pVAX1-pIL-15(50μg)联合免疫组、pVAX1空载体对照组和PBS对照组。利用淋巴细胞转化试验、酶联免疫吸附试验、流式细胞仪技术对不同处理组小鼠的各项免疫指标进行了检测。
试验结果表明,各免疫组小鼠的各项免疫指标均比pVAX1空载体对照组和PBS对照组高,加入pIL-15的结果尤为显著。在淋巴细胞转化试验和CD4+、CD8+细胞数量的变化及小鼠血液中IFN-γ的检测试验中,加pIL-15中剂量(100μg)组的效果最为明显,其次是加pIL-15小剂量(50μg )组,加pIL-15大剂量(200μg)组的效果差于以上两组,但也比pVAX1-PRRSV ORF5单独免疫组效果明显。而酶联免疫吸附试验检测抗PRRSV ORF5 IgG的结果显示,加pIL-15大剂量(200μg)组的免疫效果优于其他各组。同时在不同时间点收集组织样品,通过PCR检测pVAX1-PRRSV ORF5质粒在小鼠体内的动态分布情况。结果表明,肌肉注射核酸疫苗后,pVAX1-PRRSV ORF5迅速分布到小鼠其他组织器官中,在免疫后3 h即可在脑组织、心脏、肝脏、肺脏、肾脏中检测到,一直持续到免疫后42天。
本实验还构建了二个pGEX-6p-pIL-15原核表达质粒,二个质粒分别缺失了pIL-15 N端29 aa和48 aa信号肽序列。在大肠杆菌中获得了高效表达的pIL-15蛋白。纯化后蛋白免疫新西兰大白兔获得兔源多克隆抗体。酶联免疫吸附试验和免疫荧光结果表明pIL-15蛋白与多克隆抗体均具有生物学活性。
综上,本研究首次将pIL-15基因与PRRSV ORF5基因质粒联合免疫。实验结果表明pIL-15基因作为PRRSV ORF5抗原基因分子佐剂,不但能促进机体的细胞免疫应答,而且能够提高机体体液免疫应答,进而提高了机体的免疫反应。为进一步研究pIL-15生物活性提供了数据,同时为新型免疫增强型抗病毒疫苗的研究提供了理论基础。
In this study, PRRSV ORF5 gene and porcine IL-15 gene were inserted into the eukaryotic expression vector, pVAX1, resulting in recombinant plasmids, pVAX1-PRRSV ORF5 and pVAX1-pIL-15. The plasmids were transfected into Vero cells and the results showed that the transient expression of both genes was confirmed by respective antibodies.
Experimental mice were divided into 7 groups. They were pVAX1-PRRSV ORF5 group, pVAX1-pIL-15 group, pVAX1-PRRSV ORF5 (100μg) and pVAX1-pIL-15 (100μg) group, pVAX1-PRRSV ORF5 (100μg) and pVAX1-pIL-15 (200μg) group, pVAX1-PRRSV ORF5 (100μg) and pVAX1-pIL-15 (50μg) group, vector pVAX1 control group and PBS control group. Lymphocyte proliferative assay, enzyme linkered immunosorbent assay and flow cytometric technique were used to analyze the immune response of different groups.
The results showed that the general immune responses of five immunized groups are higher than the empty pVAX1 vector and PBS control groups. Especially, the mice inoculated with the pVAX1-PRRSV ORF5 and pVAX1-pIL-15 had higher immune response than other groups in terms of the T lymphocyte proliferative function and the number of CD4+ and CD8+ in peripheral blood and spleen as well as the levels of IFN-γin peripheral blood. In addition, the pVAX1-pIL-15 (100μg) group had the highest cellular immune responses. The pVAX1-pIL-15 (50μg) group is better than the pVAX1-pIL-15 (200μg) group in terms of the stimulation of cellular immune responses. However, the highest level of specific anti-PRRSV ORF5 antibody in peripheral blood of immunized mice was stimulated by the combinaiton of the pVAX1-PRRSV ORF5 (100μg) and pVAX1-pIL-15 (200μg). These results are helpful for analyzing the adjuvant function of pIL-15.
After inoculating different doses plasmids of pVAX1-PRRSV ORF5 and pVAX1-pIL-15 into the mice, tissue samples from different time points were collected and subjected to PCR amplifying PRRSV ORF5 gene. The results showed that the ORF5 gene is detectable shortly in mice after intramuscular injection, and it mainly can be detected in brain, heart, liver, lung and kidney from 3 h to 42 d post-immunization.
At the same time, we designed two paris of primers to amplify two truncated pIL-15 genes with deletion of either N-terminal 29 aa signal peptide or N-terminal 48 aa signal peptide. The maximum expression of the pIL-15 was determined after cloning and expression of both genes in E.coli. The pIL-15 protein was used as an immunogen to inoculate a rabbit for generation of specific polyclonal antiserum. Our results showed that both the pIL-15 and its antiserum are biologically active.
To sum up, our results indicate that pIL-15 can enhance the immune responses of DNA plasmid encoding the PRRSV ORF5 in mice. The optimal dose of the molecular adjuvant, pIL-15, is important for improvement of the DNA vaccination of PRRSV ORF5. The current study provide useful data for rational immunization of PRRSV ORF5 DNA.
试验结果表明,各免疫组小鼠的各项免疫指标均比pVAX1空载体对照组和PBS对照组高,加入pIL-15的结果尤为显著。在淋巴细胞转化试验和CD4+、CD8+细胞数量的变化及小鼠血液中IFN-γ的检测试验中,加pIL-15中剂量(100μg)组的效果最为明显,其次是加pIL-15小剂量(50μg )组,加pIL-15大剂量(200μg)组的效果差于以上两组,但也比pVAX1-PRRSV ORF5单独免疫组效果明显。而酶联免疫吸附试验检测抗PRRSV ORF5 IgG的结果显示,加pIL-15大剂量(200μg)组的免疫效果优于其他各组。同时在不同时间点收集组织样品,通过PCR检测pVAX1-PRRSV ORF5质粒在小鼠体内的动态分布情况。结果表明,肌肉注射核酸疫苗后,pVAX1-PRRSV ORF5迅速分布到小鼠其他组织器官中,在免疫后3 h即可在脑组织、心脏、肝脏、肺脏、肾脏中检测到,一直持续到免疫后42天。
本实验还构建了二个pGEX-6p-pIL-15原核表达质粒,二个质粒分别缺失了pIL-15 N端29 aa和48 aa信号肽序列。在大肠杆菌中获得了高效表达的pIL-15蛋白。纯化后蛋白免疫新西兰大白兔获得兔源多克隆抗体。酶联免疫吸附试验和免疫荧光结果表明pIL-15蛋白与多克隆抗体均具有生物学活性。
综上,本研究首次将pIL-15基因与PRRSV ORF5基因质粒联合免疫。实验结果表明pIL-15基因作为PRRSV ORF5抗原基因分子佐剂,不但能促进机体的细胞免疫应答,而且能够提高机体体液免疫应答,进而提高了机体的免疫反应。为进一步研究pIL-15生物活性提供了数据,同时为新型免疫增强型抗病毒疫苗的研究提供了理论基础。
In this study, PRRSV ORF5 gene and porcine IL-15 gene were inserted into the eukaryotic expression vector, pVAX1, resulting in recombinant plasmids, pVAX1-PRRSV ORF5 and pVAX1-pIL-15. The plasmids were transfected into Vero cells and the results showed that the transient expression of both genes was confirmed by respective antibodies.
Experimental mice were divided into 7 groups. They were pVAX1-PRRSV ORF5 group, pVAX1-pIL-15 group, pVAX1-PRRSV ORF5 (100μg) and pVAX1-pIL-15 (100μg) group, pVAX1-PRRSV ORF5 (100μg) and pVAX1-pIL-15 (200μg) group, pVAX1-PRRSV ORF5 (100μg) and pVAX1-pIL-15 (50μg) group, vector pVAX1 control group and PBS control group. Lymphocyte proliferative assay, enzyme linkered immunosorbent assay and flow cytometric technique were used to analyze the immune response of different groups.
The results showed that the general immune responses of five immunized groups are higher than the empty pVAX1 vector and PBS control groups. Especially, the mice inoculated with the pVAX1-PRRSV ORF5 and pVAX1-pIL-15 had higher immune response than other groups in terms of the T lymphocyte proliferative function and the number of CD4+ and CD8+ in peripheral blood and spleen as well as the levels of IFN-γin peripheral blood. In addition, the pVAX1-pIL-15 (100μg) group had the highest cellular immune responses. The pVAX1-pIL-15 (50μg) group is better than the pVAX1-pIL-15 (200μg) group in terms of the stimulation of cellular immune responses. However, the highest level of specific anti-PRRSV ORF5 antibody in peripheral blood of immunized mice was stimulated by the combinaiton of the pVAX1-PRRSV ORF5 (100μg) and pVAX1-pIL-15 (200μg). These results are helpful for analyzing the adjuvant function of pIL-15.
After inoculating different doses plasmids of pVAX1-PRRSV ORF5 and pVAX1-pIL-15 into the mice, tissue samples from different time points were collected and subjected to PCR amplifying PRRSV ORF5 gene. The results showed that the ORF5 gene is detectable shortly in mice after intramuscular injection, and it mainly can be detected in brain, heart, liver, lung and kidney from 3 h to 42 d post-immunization.
At the same time, we designed two paris of primers to amplify two truncated pIL-15 genes with deletion of either N-terminal 29 aa signal peptide or N-terminal 48 aa signal peptide. The maximum expression of the pIL-15 was determined after cloning and expression of both genes in E.coli. The pIL-15 protein was used as an immunogen to inoculate a rabbit for generation of specific polyclonal antiserum. Our results showed that both the pIL-15 and its antiserum are biologically active.
To sum up, our results indicate that pIL-15 can enhance the immune responses of DNA plasmid encoding the PRRSV ORF5 in mice. The optimal dose of the molecular adjuvant, pIL-15, is important for improvement of the DNA vaccination of PRRSV ORF5. The current study provide useful data for rational immunization of PRRSV ORF5 DNA.
引文
蔡宝祥. 1995.猪繁殖与呼吸综合征研究进展.中国兽医学报[J]. 15(4): 412-416
蔡雪晖,柴文君,翁长江. 2000.猪繁殖与呼吸综合症及其在我国的现状与对策.中国预防兽医学报[J]. 22: 202-205
陈创夫,余兴龙,马正海等. 2002.猪瘟基因疫苗在小鼠肌肉中的动态分布表达.畜牧兽医学报[J]. 33(3): 250-284
豆文波. 2005.猪繁殖与呼吸综合症病毒ORF5基因疫苗在小鼠体内动态分布与表达[D]. 绵阳:四川农业大学.研究生学位论文
樊福好. 2005.关于蓝耳病免疫的是是非非.畜禽业[J].(6): 6-9
房文亮,王永祥,金玉怀等. 2003. IL-15基因真核表达质粒的构建及其对CVB3 VP1基因疫苗的免疫增强作用.河北医科大学学报[J]. 24(3): 129-132
高云英,贺玉胜,刘秀琴等. 2002.猪繁殖与呼吸综合症研究进展.甘肃农业大学学报[J]. 37(6): 139-144
郭宝清,陈章水,刘文兴. 1996.从疑似PRRSV流产胎儿分离PRRSV的研究.中国畜禽传染病[J]. 2: 1-4
郭海龙. 2002.猪繁殖与呼吸综合征病毒感染猪体内细胞因子与病毒的定量检测[D].北京:中国农业科学院.硕士研究生学位论文
韩国全,郭万柱,孙志勇. 2008.猪霍乱沙门菌SC500运载TGEV S与猪IL-15融合基因疫苗的稳定性及免疫安全性.中国兽医科学. 38(10): 871-877
韩国全,郭万柱,王印等. 2009.内江猪IL-15基因的表达与免疫增强作用研究.中国兽医科学[J]. 39(06): 543-549
和晶亮. 2007. DNA疫苗的相关研究进展[J].动物医学进展. 28(增): 44-47
胡慧琼. 2006.四川山地乌骨鸡IL-2、15、18、IFN-γ基因克隆测序及分子佐剂效应研究[D].绵阳:四川农业大学.博士研究生学位论文
姜平. 2002.猪繁殖与呼吸综合征病毒研究新进展.丁壮,万遂如,金宁一,等.猪的重要传染病防治研究新成果. 2002.重庆:中国畜牧兽医学会家畜传染病学分会[J]. 84-88
江云波,方六荣,肖少波. 2007.猪白细胞介素15基因的克隆及在大肠杆菌中的表达.畜牧兽医学报[J]. 38(8): 841-845
J萨姆布鲁克, E F弗里奇, T曼尼阿蒂斯. 1996.分子克隆实验指南[M].第2版,北京: 北京科学出版社, 775-776
金伯泉. 2001.细胞和分子免疫学[M].北京:科学出版社. 131-239
金苗苗,沈国顺,张敏等. 2007.猪繁殖与呼吸综合征疫苗的研究进展.黑龙江畜牧兽医[J]. 06: 17-18
李成,李六金,谷守林. 2001.猪繁殖与呼吸综合症病毒形态学特征.畜牧兽医学报[J]. 32(6): 563-567
李华,杨汉春,许勇钢等. 2001.猪繁殖与呼吸综合征病毒感染仔猪淋巴细胞亚群的动态.兽医免疫学杂志[J]. 17(4): 208-211
刘芳,汪铭书,程安春等. 2005.人工感染PRRSV仔猪肺和子宫细胞凋亡的电镜观察.中国兽医科技[J]. 35(5): 327-332
刘光清,蔡雪晖,仇华吉等. 2001.猪繁殖与呼吸综合征的研究进展.中国预防兽医学报[J]. 23(1): 72-76
刘书亮,王红宁. 2000. PRRS的病原学和免疫学研究进展.四川畜牧兽医[J]. 27(7): 79-83
刘伍梅,汪铭书,程安春. 2005. DNA Ladder和ELISA联合检测PRRSV诱导Marc145细胞凋亡动态变化规律的研究.四川农业大学学报[J]. 23(1): 95-98
骆爱芳,郭万柱,宋振辉等. 2007.猪白细胞介素-15基因的克隆及生物信息学分析.中国畜牧兽医[J]. 34(10): 37-40
磨美兰. 2005. PRRSV感染对猪肺泡巨噬细胞外源性抗原加工递呈功能的影响[D].北京:中国农业大学.博士研究生学位论文
仇华吉,童光志. 2000.猪繁殖与呼吸综合症[M].吉林:科学技术出版社
孙欣,高顺强. 2007. IL-15表达质粒联合HPV基因疫苗诱导细胞免疫应答的实验研究.中国艾滋病性病[J]. 13(5): 417-419
田志军. 2005.表达PRRSV GP5蛋白的重组伪狂犬病毒的构建及其免疫效力的研究[D]. 哈尔滨:东北农业大学.博士研究生毕业论文
许立华,王玲,刘华雷. 2004.猪繁殖与呼吸综合征病毒分子生物学研究进展.宁夏农学院学报[J]. 25(2): 71-75
汪铭书,程安春,刘芳等. 2006.仔猪人工感染猪繁殖与呼吸综合征病毒后宿主细胞凋亡动态变化规律的研究.病毒学报[J]. 22(5): 385-390
温建新,李俊,周顺. 2008.含CpG序列PRRSV ORF5基因真核质粒构建及其免疫原性的研究.中国农业科学[J]. 41(5): 1503-1510
希尼尼根. 2004.猪呼吸与繁殖综合症病毒ORF5核酸疫苗的研究[D].绵阳:四川农业大学.博士研究生学位论文
杨春艳,苏先狮,李曼妮. 2004.白细胞介素IL-15重组体对HBsAg核酸疫苗的免疫佐剂作用.中华肝脏病杂志[J]. 12(12): 758-759
杨克礼,梁望旺,伍锐. 2009.母猪接种PRRS疫苗预防PRRSV垂直传播的效果.湖北农业科学[J]. (48)12: 3092-3094
殷震,刘景华. 1997.动物病毒学[M].第二版.北京:科学出版社
于在江,马学恩,周建华. 2007.切胶纯化表达蛋白包涵体的可行性分析.生物技术[J]. 3: 46-48
张成裕. 2004.免疫增强剂在动物医学上的研究进展及应用.福建畜牧兽医[J]. 26(增): 61-63
张晓梅,杨汉春,李华等. 1999.猪繁殖与呼吸综合征病毒实验感染SPF猪外周血单核细胞和肺泡巨噬细胞早期凋亡细胞的观察.中国兽医杂志[J]. 25(11): 11-13
周艳君,仇华吉,童光志. 2000.猪生殖-呼吸综合症病毒研究进展.中国预防兽医学报[J]. 2(3): 12-18
周艳君,仇华吉,王云峰等. 2000.应用杆状病毒系统高效表达猪繁殖与呼吸道综合症病毒GP5基因.中国预防兽医学报[J]. 22(4): 278 - 280
Ana C, David R G, Louis C G, et al. 1997. Molecular cloning of cDNA encoding porcine interleukin 15. Gene[J]. 195: 337-339
Albina E. 1997. Epidemiology of porcine and respiratory syndrome (PRRS): an overview. Vet Microbiol[J]. 55: 309-316
Albina, E, Carrat C, Charley B. 1998. Interferon-αresponse to swine arterivirus (PoAV), the porcine reproductive and respiratory syndrome virus. Journal of Interferon and Cytokine Research [J]. 18: 485–490
Allende R, Lewis TL, Lu Z, et al. 1999. North American and European porcine reproductive and respiratory syndrome viruses differ in non- structural protein coding regions. Gen Virol[J]. 80: 307-315
Asai T, Mori M, Okada M, et al. 1999. Elevated serum haptoglobin in pigs infected with porcine reproductive and respiratory syndrome virus. Veterinary Immunology and Immunopathology[J]. 70: 143–148
Aucoutorier J, Dupuis L, Ganne V. 2001. Adjuvants designed for veterinary and human vaccines. Vaccine[J]. 19 (17-19): 2666-2672
Aurora Fernández, Paloma Suárez, JoséMaría Castro, et al. 2002. Characterization of regions in the GP5 protein of porcine reproductive and respiratory syndrome virus required to induce apoptotic cell death. Virus Research[J]. 2 (83): 103-118
Balasuriya U B, MacLachlan N J. 2004. The immune response to equine arteritis virus: potential lessons for other arteriviruses. Vet Immunol Immunopathol[J]. 102: 107–129
Barfoed AM, Blixenkrone-Moller M, Jensen MH, Botner A, et al. 2004. DNA vaccination of pigs with open reading frame 1-7 of PRRS virus. Vaccine[J]. 22 (27-28): 28-41
Barry S, Peters, Walter Jaoko, et al. 2006. Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA)with and without DNA priming: Effects of dosage and route on safety and immunogenicity. Vaccine[J]. 25 (11): 2120-2127
Bastos RG, Dellagostin OA, Barletta RG, et al. 2004. Immune responses of pigs inoculated with Mycobacterium bovis BCG expressing atruncatedform of GP5 and M protein of porcine reproductive and respiratory syndrome virus. Vaccine[J]. 22 (4): 67–74
Bautista EM, Molitor TW. 1997. T cell response to the structural polypeptides of porcine reproductive and respiratory syndrome virus. Arch Virol[J]. 144: 117–1134
Bautista E M, Molitor T W. 1997. Cell-mediated immunity to porcine reproductive and respiratory syndrome virus in swine. Viral Immunology[J]. 10: 83–94
Bautista E M, Molitor T W. 1999. IFN-gamma inhibits porcine reproductive and respiratory syndrome virus replication in macrophages. Arch Virol[J]. 144 (6): 1191-200
Becker T C, Wherry E J, Boone D, et al. 2002. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8+ T cells. Exp Med[J]. 195: 1541–1548
Benfield D A, Nelson E, Collins J E, et al. 1992. Characterization of swine infertility and respiratory syndrome (SIRS) virus (isolate ATCC VR-2332). Vet Diagn Invest[J]. 4: 127–133
Benson J E. 2002. Functional properties of the predicted helicase of porcine reproductive and respiratory syndrome virus. Virol[J]. 19 (1): 235-241
Bilodeau R, Dea S, Martineau G P, et al. 1991. Porcine reproductive and respiratory syndrome in Quebec. Vet Rec[J]. 129: 102-103
Blaha T. 2000. The“colorful”epidemiology of PRRS. Vet Res[J]. 31 (1): 77-83
Bastos RG, Dellagostin O A, Barletta R G, et al. 2004. Immune response of pigs inoculated with Mycobacterium bovis BCG expressing a truncated form of GP5 and M protein reproductive and respiratory syndrome virus. Vaccine[J]. 22 (3/4): 467-474
Buddaert W, Van Reeth K, Pensaert M. 1998. In vivo and in vitro interferon (IFN) studies with the porcine reproductive and respiratory syndrome virus (PRRSV). Advances in Experimental Medicine and Biology[J]. 440: 461–467
Brievly I, Diggard P, Inglis S C. 1989. Characterization of an efficient Coronavirus ribosomal frameshifting signal: requirement for an RNA Pseudoknot. Cell[J]. 57: 537-547
Bruin M GM, SamsomJ N. 2000. Effects of a porcine reproductive and respiratory syndrome virus infection on the development of the immune response against pseudorabies virus. Veterinary Immunology and Immunopathology[J]. 76: 125-135
Cafruny W A, Bradley S E, Rowland R R. 1999. Regulation of immune complexes during infection of mice with lactate dehydrogenase-elevating virus: studies with interferon-gamma gene knockout and tolerant mice. Viral Immunol[J]. 12: 163–173
Cancel-Tirado SM, Evans RB, Yoon KJ. 2004. Monoclonal antibody analysis of porcine reproductive and respiratory syndrome virus epitopes associated with antibody-dependent enhancement and neutralization of virusinfection. Vet Immunol Immunopatho[J]. l102 (3): 249–262
Cavanaugh D. 1997. Nidovirales: a new order comprising Coronaviridae and Arteriviridae. Arch Vitol[J]. 142: 629-633
Charerntantanakul W, Platt R, Roth J A. 2006. Effects of porcine reproductive and respiratory syndrome virus-infected antigen-presenting cells on T cell activation and antiviral cytokine production. Viral Immunology[J]. 19: 646–661
Chehimi J, Marshall J D, Salvucci O, et al. 1997. IL-15 enhances immune functions during HIV infection. Immunol[J]. 158: 5978–5987
ChunS, DaheshiaM, LeeS, et al. 1999. Distribution fate and mechanism of immune modulation following mucosal delivery of plasmid DNA encoding IL-10. Irnrnunol[J]. 163 (5): 2393
Conzelmann K K, Visser N, Van Woensel P, et al. 1993. Molecular characterization of porcine reproductive and respiratory disease virus, a member of the arterivirus group. Virology[J]. 193: 329-339
Collins J E, Benfield D A, Christianson W T, et al. 1992. Isolation of swine infertility and respiratory syndrome virus (isolate ATCC VR-2332) in North America and experimental reproduction of the disease in gnotobiotic pigs. Vet Diagn Invest[J]. 4: 117–126
Coutelier J P, Van Snick J. 1988. Neautralization and sensitization of lactate dehydrogenase-elevating virus with monoclonal antibodies. Gen Virol[J]. 69: 2097-2100
Cox J C, Coulter A R. 1997. Adjuvants-a classification and review of their modes of action. Vaccine[J]. 15: 248
Christopher-Hennings J, Nelson E A, Nelson J K, et al. 1997. Effects of a modified-live virusvaccine against porcine reproductive and respiratory syndrome in boars. Vet Res[J]. 58: 40–45
de Limaa M, Pattnaika AK, Flores EF, et al. 2006. Serologic marker candidates identified among B-cell linear epitopes of Nsp2 and structural proteins of a North American strain of porcine reproductive and respiratory syndrome virus. Virology[J]. 353 (2): 410–421
Dea S, Gagonon C A, Mardassi H, et al. 1996. Antigenic variability among North American and European strains of porcine reproductive and respiratory syndrome virus as defined by monoclonal antibodies to the matrix protein. Clin Microbiol[J]. 34: 1488-1493
Dea S, Gagnon C A, Mardassi H, et al. 2000. Current knowledge on the structural proteins of porcine reproduetive and respiratory syndrome (PRRS) virus: comparion of the North American and European isolates. Arch Virol[J]. 145 (4): 659-688
de Lima M, Pattnaik A K, Flores E F, et al. 2006. Serologic marker candidates identified among B-cell linear epitopes of Nsp2 and structural proteins of a North American strain of porcine reproductive and respiratory syndrome virus. Virology[J]. 30: 410–421
Delputte P L, Meerts P, Costers S, et al. 2004. Effect of virus-specific antibodies on attachment, internalization and infection of porcine reproductive and respiratory syndrome virus in primary macrophages. Veterinary Immunology and Immunopathology[J]. 102: 179–188
de Vries A A F, Post S M, Raamsman M J B, et al. 1995. The two major envelope proteins of equine arteritis virus associate into disulfide-linked heterodimers. Virol[J]. 69: 4668-4674
Diaz I, Darwich L, Pappaterra G, et al. 2005. Immune responses of pigs after experimental infection with a European strain of Porcine reproductive and respiratory syndrome virus. Gen. Virol[J]. 86: 1943–1951
Diaz I, Darwich L, Pappaterra G, et al. 2006. Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs. Virology[J]. 351: 249–259
E Mateu, I Diaz. 2008. The challenge of PRRS immunology. Veterinary[J]. 177: 345–351
Fang L R, Jiang Y B, Xiao S B, et al. 2006. Enhanced immunogenicity of the modified GP5 of porcine reproductive and respiratory syndrome virus. Virus Genes[J]. 32 (1): 5-11
Fernandez A, Suarez P, Castro J M, et al. 2002. Characterization of regions in the GP5 protein of porcine reproductive and respiratory syndrome virus required to induce apoptotic cell death. Virus Res[J]. (83): 103-118
Foss D L, Zilliox M J, Meier W, et al. 2002. Adjuvant danger signals increase the immune response to porcine reproductive and respiratory syndrome virus. Viral Immuno[J]. l15 (4): 557-66
Gagnon C A, Lachapelle G, Langelier Y, et al. 2003. Adenoviral expressed GP5 of porcine reproductive and respiratory syndrome virus differs in its cellular maturation from the authentic viral protein but maintains known biological functions. Arch Virol[J]. 148: 951-972
Grabstein K H, Eisenman J, Shanebeck K, et al. 1994. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science[J]. 264: 965-968
Hong-Xiang Sun, Hui Wang, Hai-shun Xu, et al. 2009. Novel polysaccharide adjuvant from the roots of Actinidia eriantha with dual Th1 and Th2 potentiating activity. Vaccine[J]. 27: 3984–3991
Huang T S, Jong M H, Tu W J, et al. 2000. Differentiation of Taiwan porcine reproductive and respiratory syndrome virus isolates by RT-PCR amplification. Exp Rep NIAH[J]. 36: 23–28
I Díaz, L Darwich, G Pappaterra, et al. 2006. Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs. Virology[J]. 351: 249–259
Jiang W, Jiang P, Li Y, et al. 2006. Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice. Vet Immunol Immunopathol[J]. 113: 169–180
Jiangmei Yin, Anlan Dai, Dominick J, et al. 2009. High dose of plasmid IL-15 inhibits immune responses in an influenza non-human primates immunogenicity model. Virology[J]. 393: 49–55
Jiang Y B, Fang L R, Xiao S B, et al. 2007. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus. Vaccine[J]. 25: 547–60
Jinyan Liu, Michael Hellerstein, Michael McDonnel, et al. 2007. Dose–response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost. Vaccine[J]. 25: 2951–2958
Juas E R, Inaba Y, Kolone M, et al. 1996. Hemagglutination with PRRSV. Veterinary Medical Science[J]. 58 (6): 521-527
Joshua S, Ellingson, Yue Wang, et al. 2005. Vaccine efficacy of porcine reproductive and respiratory syndrome virus chimeras. Vaccine[J]. 108: 98-109
Kensil C R, Wu J-Y, Soltysik S. 1995. Structural and immunological characterization of the vaccine adjuvant QS-21. Vaccine design: the subunit and adjuvant approach. New York[J]. PlenumPress: 525–541
Keffaber K K. 1989. Reproductive failure of unknown etiology. Am Assoc Swine Pract Newsl[J]. 1: 1-19
Kheyar A, Jabrane A, Zhu C, et al. 2005. Altern ative codon usage of PRRS virus ORF5 gene increases eukaryotic expression of GP5 glycoprotein and improves immune response in challengedpigs. Vaccine[J]. 23: 4016–4022
Kim JJ, Ayyavoo V, Bagarazzi ML, et al. 1997. In vivo engineering of a cellular immune response by coadministration of IL-12 expressin vector with a DNA immunogen. Immunol[J]. 158 (2): 816-826
Kim J J, Trivedi N N, Nottingham L K, et al. 1998. Modulationof amplitude and direction of in vivo immune responses by coadministration of cytokine gene expression cassettes with DNA immunogens. Immunol[J]. 28 (3): 1089-1103
Kim J J, Simbiri KA, Sin JI, et al. 1999. Cytokine molecular adjuvants modulate immune responses induced by DNA vaccine constructs for HIV-1 and SIV. InterferonCytokineRes[J]. 19: 77
Kim J J, Yang J S, Manson K H, et al. 2001. Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvant. Vaccine[J]. 19: 2496
Kim S H, ChoD, Kim T S. 2001. Induction of in vivo resistance to Mycobacterium avium infection by intramuscular injection with DNA encoding interleukin-18. Immunology[J]. 102: 234
Kozak M. 1987. An analysis of 5-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res[J]. 15 (20): 8125-8140
Ku C C, Murakami M, Sakamoto A,et al. 2000. Control of homeostasis of CD8+memory T cells by opposing cytokines. Science[J]. 288: 655–678
Kutzler M A, Robinson T M, Chattergoon M A, et al. 2005. Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8+ T cells that are partially independent of CD4+ T cell help. Immunol[J]. 175: 112–123
Kwang J, Zuckermann F, Ross G. 1999. Antibody and cel llar Immune responses of swine following immunization with plasmid DNA encoding the PRRS virus ORFs4, 5, 6 and 7. Veterinary Science[J]. 67: 199-201
Labarque G G, Nauwynck H J, van Reeth K, et al. 2001. Apoptosis in the lungs of pigs during an inoculation with a European strain of porcine reproductive and respiratory syndrome virus. Adv Exp Med Biol[J]. 494: 691-697
Labarque G, Van Gucht S, VanReeth K, et al. 2003. Respiratory tract protection upon challenge of pigs vaccinated with attenuated porcine reproductive and respiratory syndrome virus vaccines. Vet Microbiol[J]. 95: 187–197
Labarque G, Van Gucht S, Nauwynck H, et al. 2003. Apoptosis in the lungs of pigs inoculated with porcine reproductive and respiratory syndrome virus and associations with the production of apoptogenic cytokines. Vet Res[J]. 34 (3): 249-260
Labarque G, Reeth K V, Nauwynck H, et al. 2004. Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy. Vaccine[J]. 22: 4183–4190
Lager K M, Mengeling W L, Brockmeier S L. 1999. Evaluation of protective immunity in gilts inoculated with the NADC-8 isolate of porcine reproductive and respiratory syndrome virus (PRRSV) and challenge-exposed with an antigenically distinct PRRSV isolate. American Journal of Veterinary Research[J]. 60: 1022–1027
Lagging L M, Meyer K, Hotf D, et al. 1995. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. Virol[J]. 69 (9): 5859-5863
Lee S M, Schommer S K, Kleiboeker S B. 2004. Porcine reproductive and respiratory syndrome virus field isolates differ in in vitro interferon phenotypes. Veterinary Immunology and Immunopathology[J]. 102: 217–231
Lee S M, Kleiboeker S B. 2005. Porcine arterivirus activates the NF-k B pathway through Ik B degradation. Virology[J]. 342: 47–59
Loemba H D, Mounir S, Mardassi H, et al. 1996. Kinetics of humoral immune response to the major structural proteins of the porcine reproductive and respiratory syndrome virus. Archives of Virology[J]. 141: 751–761
Lopez Fuertes L, Domenech N, Alvarez B, et al. 1999. Analysis of cellular immune response in pigs recovered from porcine respiratory and reproductive syndrome infection. Virus Research[J].64: 33–42
Lopez O J, Osorio F A. 2004. Role of neutralizing antibodies in PRRSV protective immunity. Vet Immunol Immunopathol[J]. 102: 155–163
Lopez O J, Oliveira M F, Garcia E A, et al. 2007. Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent. Clinical and Vaccine Immunology[J]. 14: 269–275
Lovell D. 2004. Biologic agents for the treatment of juvenile rheumatoid arthritis: current status. Paediatr Drugs[J]. 6 (3): 137-146
Luxembourg B and Lindhoff-Last E. 2007. Genomic diagnosis of thrombophilia in women: clinical relevance H mostaseologie[J]. 27: 22–31
Mardassi H, Athanassious R, Mfounir S, et al. 1994. Porcine reproductive and respiratory syndrome virus: morphological, biochemical and serological characteristics of Quebec isolates associated with acute and chronic outbreaks of porcine reproductive and respiratory syndrome. Can J Vet Res[J]. 58: 55-64
Mardassi H, Massie B, Dea S. 1996. Intracellular synthesis, processing, and transport of proteins encoded by ORFs 5 to 7 of porcine reproductive and respiratory syndrome virus. Virology[J]. 221: 98-112
Mariela Scortti, Cinta Prieto, Francisco J, et al. 2006. Effects of two commercial European modified-live vaccines against porcine reproductive and respiratory syndrome viruses in pregnant gilts. Veterinary[J]. 172: 506-514
Marshall J D, Fearon K L, Higgins D, et al. 2005. Superior activity of the type C class of ISS in vitro and in vivo across multiple species. DNA Cell Biol[J]. 24: 63–72
Meier W A, Galeota J, Osorio F A, et al. 2003. Gradual development of the interferon-gamma response of swine to porcine reproductive and respiratory syndrome virus infection or vaccination. Virology[J]. 309: 18–31
Mengeling W L, Lager K M, Vorwald A C. 1999. Safety and efficacy of vaccination of pregnant gilts against porcine reproductive and respiratory syndrome. Vet Res[J]. 60: 796–801
Mengeling W L, Lager K M, Vorwald A C, et al. 2003a. Comparative safety and efficacy of attenuated single-strain and multi-strain vaccines for porcine reproductive and respiratory syndromeVet. Microbiol[J]. 93: 25–38
Mengeling W L, Lager K M, Vorwald A C, et al. 2003b. Strain specificity of the immune response of pigs following vaccination with various strains of porcine reproductive and respiratory syndrome virus. Vet Microbiol[J]. 93: 13–24
Meng X J, Paul P S, Halbur P G. 1994. Molecular cloning and nucleotide sequencing of the 3’terminal genomic RNA of porcine reproductive and respiratory syndrome virus. Gen V irol[J]. 75: 1795-1801
Meulenberg J J, Hulst M M, De Meijer E J, et al. 1993a. Lelystad virus, the caustive agent of porcine epidemic abortion and respiratory syndrome (PEARS), is related to LDV and EAV. V irology[J]. 192: 62-72
Meulenberg J J, Besten A, De kluyver, et al. 1995. Characterization of protein encoded byORFs 2 to 7 of lelystad virus. Virology[J]. 206: 155-163
Meulenberg J J M, Petersen-den Besten A. 1996. Identification and characterization of a sixth structural protein of Lelystad Virus: the glycoprotein GP2 encoded by ORF2 is incorporated in virus particle. Viroligy[J]. 225: 44-51
Meulenberg J J, Petersenden Besten A, deKluyver E, et al. 1997. Molecular characterization of Lelystad virus. Veterinary Microbiology[J]. 55: 197–202
Meulenberg J J M. 2000. PRRSV, the Virus. Vet Res[J]. 31: 11-21
Min W, Lillehoj H S, Burnside J, et al. 2001. Adjuvant effects of IL-1beta, IL-2, IL-8, IL-15, IFN-alpha, IFN-gamma, TGF-beta 4 and lymphotactin on DNA vaccination against Eimeria acervulina. Vaccine[J]. 20 (122): 267-274
Molitor T W, Bautista E M, Chli C S. 1997. Immunity to PRRSV: Double-edged sword. Vet Mocrobio[J]. 55: 265-276
Mueller Y M, Do D H, Altork S R, et al. 2008. IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses. Immunol[J]. 180: 350–360
Murtaugh M P, Wlam M R, Kakach L T. 1995. Comparison of the structural protein coding sequences of the VR-2332 and Lelystad virus strains of the PRRS virus. Arch Virol[J]. 140: 1451-1460
Nelsen C J, Murtaugh M P, Faaberg K S. 1999. Porcine reproductive and respiratory syndrome virus comparison: Divergent evolution on two continents. Virol[J]. 73: 270-280
Nielson R and Botner A. 1997. Hematologieal and irnrnunologieal Parameters of 4.5-month old pigs infeeted with PRRS virus. Veterinary Microbiology[J]. 55: 289-294
Nelson E A, Christopher-Hennings J, Drew T, et al. 1993. Differentiation of US and European isolates of porcine reproductive and respiratory syndrome virus by monoclonal antibodies. Clin Microbiol[J]. 31: 3184–3189
Nelson E A, Christopher-Hennings J, Benfield D A. 1994. Serum immune responses to the proteins of porcine reproductive and respiratory syndrome (PRRS) virus. Journal of Veterinary Diagnostic Investigation[J]. 6: 410–415
Norman J A, Hobart P. 1997. Development of improved vectors for DNA-based immunization and other gene therapy applications. Vaccine[J]. 15 (8): 801-803
Oleksiewicz M B, Nielsen J. 1999. Effect of porcine reproductive and respiratory syndrome virus (PRRSV) on alveolar lung macrophage survival and function. Vet Microbiol[J]. 66: 15–27
Oleksiewicz M B, Botner A, Toft P, et al. 2001. Epitope mapping porcine reproductive and respiratorysyndrome virus by phage display: the nsp2 fragment of the replicase polyprotein contains a cluster of B-cell epitopes. Virology[J]. 75: 3277–3290
Onyekaba C O, Harty J T, Even C, Hu B G, et al. 1989. Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses. Virus Res[J]. 14: 297–315
Osorio F A, Galeota J A, Nelson E, et al. 2002. Passive transfer of virus-specific antibodiesconfers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity. Virology[J]. 302: 9–20
Ostrowski M, Galeota J A, Jar A M, et al. 2002. Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain. Virol[J]. 76 (9): 4241–4250
trick G, Pirzadeh B, Gagnon C A, et al. 1999. Seroneutralization of porcine reproductive and respiratory syndrome virus correlates with antibody response to the GP5 major envelope glycoprotein. Vet Diagn Invest[J]. 11: 20–26
Pejsak Z, Stadejek T, Markowska-Daniel I. 1997. Clinical signs and economic losses caused by porcine reproductive and respiratory syndrome virus in a large breeding farm. Vet Microbiol[J]. 55: 317–322
Pizadeh B, Dea S. 1997. Monoclonal antibodies to ORF5 product of porcine reproductive and respiratory syndrome virus define linear neutralizing determinants. Gen Virol[J]. 78: 1867-1873
Plagemann P G, Rowland R R, Faaberg K S. 2002. The primary neutralization epitope of porcine respiratory and reproductive syndrome virus strain VR-2332 is located in the middle of the GP5 ectodomain. Arch Virol[J]. 147: 2327–2347.
Plagemann P G. 2004. GP5 ectodomain epitope of porcine reproductive and respiratory syndrome virus, strain Lelystad virus.Virus Res[J]. 102: 225–230
Plana Duran J, liment I, Sarraseca J, et al. 1997. Baculovrius expression of proteins of porcine reproductive and respiratory syndrome virus strainOlot/91 involvement of ORF3 and ORF5 proteins in protection. Virus Genes[J]. 14: 19–29
Plana-Duran J, Bastons M, Urniza A, et al. 1997. Efficacy of an inactivated vaccine for prevention of reproductive failure induced by porcine reproductive and respiratory syndrome virus. Vet Microbiol[J]. 55: 361–370
Planat Duran J, Bastons M, Urniza A, et al. 1997. Efficacy of an inactivated vaccine for prevention of reproductive failure induced by porcine reproductive and respiratory syndrome virus. Vet Microbiol[J]. 55 (14): 361-370
Pol J M A, Wagenaar F, Reus J E G. 1997. Comparative morphogenesis of three PRRS virus strains. Vet Microbiol[J]. 55: 203-208
Qiu H J, Tian Z J, Tong G Z, et al. 2005. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets. Vet Immunol Immunopathol[J]. 106: 309–319
Rakhmilevich A L, Jamssem K, Turner J, et al. 1997. Cytokine genetherapy of cancer using gene gun technology: superior antitum or activity of interleukin-12. Human Gene Therapy[J]. 8: 1303
Ribic R, Habjanec L, Brgles M, et al. 2009. Novel Mannosyl Derivatives of peptidoglycan monomer: Synthesis and biological evaluation of immunomodulatory properties. Bioorganic &Medicinal Chemistry[J]. 17: 6096-6105
Rowland R R, Robinson B, Stefanick J, et al. 2001. Inhibition of porcine reproductive and respiratory syndrome virus by interferon-gamma and recovery of virus replication with2-aminopurine. Arch Viro[J]. 146 (3): 539-555
Royaee A R, Husmann R J, Dawson H D, et al. 2004. Deciphering the involvement of innate immune factors in the development of the host response to PRRSV vaccination. Veterinary Immunology and Immunopathology[J]. 102: 199–216
San gkon O H, Berzofsky J A, Burke DS, et al. 2003. Coadministration of HIV vaccine vectors with vaccinia virusesexpressing IL-15 but not IL-2 induces long-lasting cellular immunity. PNAS[J]. 100: 3392-3397
Schijns V E. 2003. Mechanisms of vaccine adjuvant activity: initiation and regulation of immune responses by vaccine adjuvants. Vaccine[J]. 21: 829
Schirmbeck R, Melber K, Mertens T, et al. 1994. Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implications for the pathogenesis of HBV-induced hepatitis. Viro[J]. l68: 1418–1425
shimizu M, Yamada S. 1996. Change of lymphocyte populations in pigs infection with porcine reproductive and respiratory syndrome (PRRS) virus. Vet Immunol immunopathol[J]. 50: 19-27
Sin J I, Kim J J, Boyer J D, et al. 1999. In vivo modulation of vaccine induced immune responses towarda Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model. Viro1[J]. 73 (1): 501-509
Sirinarumitr T, Zhang Y, Kluge J P, et al. 1998. A pneumo-virulent United States isolate of porcine reproductive and respiratory syndrome virus induces apoptosis in bystander cells both in vitro and in vivo. Gen Viro[J]. l79: 2989–2995
Song K, Chang Y, Prudhomme G J. 2000. Regulation of T-helper-1versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and non viral cytokine gene transfer. GeneTherapy[J]. 7: 481
Suarez P, Diaz-Guerra M, Prieto C, et al. 1996. Open reading frame 5 of porcine reproductive and respiratory syndrome virus as a cause of virus-induced apoptosis. Virol[J]. 70 (5): 2876-2882
Suradhat S, Thanawongnuwech R, Poovorawan Y. 2003. Upregulation of IL-10 gene expression in porcine peripheral blood mononuclear cells by porcine reproductive and respiratory syndrome virus. General Virology[J]. 84: 453–459
Sur J H, Doster A R, Christian J S, et al. 1997. Porcine reproductive and respiratory syndrome virus replicates in testicular germ cells, alters spermatogenesis, and induces germ cell death by apoptosis. Virol[J]. 71 (12): 9170-9179
Takikawa N, Kobayashi S, Ide S, et al. 1996. Detection of antibodies against porcine reproductive and respiratory syndrome(PRRS)virus in swine sera by enzyme-linked immunosorbent assay. Veterinary Medical Science[J]. 58: 355–357
Tascon R E, Stavro pulos E, Lukacs K V, et al. 1998. Protection against Mycobacterum tuberculosis infection by CD8 T cells requires the production of gamma interferon IfectImmun[J]. 66: 830-834
Thanawongnuwech R, Thacker B, Halbur P, 2004. Increased production of proinflammatory cytokines following infection with porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae. Clinical and Diagnostic Laboratory Immunology[J]. 11: 901–908
Torremorrel M, Pijoan C, Janni K, et al. 1997. Airborne transmission of Actinobacillus pleuropneumoniae and porcine reproductive and respiratory syndrome virus in nursery pigs. Vet Res[J]. 58: 828–832
Yaeger M J, Prieve T, Collins J, et al. 1993. Evidence for the transmission of porcine reproductive and respiratory syndrome (PRRSV)virus in boar semen. Swine Hlth Prod[J]. 1: 5–9
Van Reeth K, Labarque G, Nauwynck H, et al. 1999. Differential production of proinflammatory cytokines in the pig lung during different respiratory virus infections: correlations with pathogenicity. Research in Veterinary Science[J]. 67: 47–52
Vezina S A, Loemba H, Fournier M, et al. 1996. Antibody production and blastogenic response in pigs experimentally infected with porcine reproductive and respiratory syndrome virus. Canadian Journal of Veterinary Research[J]. 60: 94–99
Voicu I L, Silim A, Morin M, et al. 1994. Interaction of porcine reproductive and respiratory syndrome virus with swine monocytes. Veterinary Record[J]. 134: 422–423
Wang C, Huang T S, Huang C C, et al. 2004. Characterization of porcine circovirus type 2 in Taiwan. Vet Med Sci[J]. 66: 469–475
Wang X, Eaton M, Mayer M, et al. 2007. Porcine reproductive and respiratory syndrome virus productively infects monocyte-derived dendritic cells and compromises their antigen-presenting ability. Archives of Virology[J]. 152: 289–303
Weiland E, Wieczorek-Krohmer M, Kohl D, et al. 1999. Monoclonal antibodies to the GP5 of porcine reproductive and respiratory syndrome virus are more effective in virus neutralization than monoclonal antibodies to the GP4. Vet Microbiol[J]. 66: 171-186
Wensvoort T, Terpstra C, Pol J, et al. 1991. Blue ear disease of pigs. Vet Rec[J]. 128: 574
Wensvoort G, deKluyver E P, Pol J M, et al. 1992. Lelystad virus, the cause of porcine epidemic abortion and respiratory syndrome: a review of mystery swine disease research at Lelystad. Vet Microbiol[J]. 33: 185–193
Wills R W, Zimmerman J J, Yoon K J, et al. 1997. Porcine reproductive and respiratory syndrome virus: routes of excretion. Vet Microbiol[J]. 57: 69–81
Wissink E H, vanWijk H A, Kroese M V, et al. 2003. The major envelope protein, GP5, of a European porcine reproductive and respiratory syndrome virus contains a neutralization epitope in its N-terminal ectodomain. Gen Virol[J]. 84: 1535–1543
Wolfgang W, Leitner Han Ying, Nicholas P. 1999. DNA and RNA-based vaccines: principles, progress and prospects. Vaccine[J]. 10 (18): 9-10
Wu W H, Fang Y, Rowland R R, et al. 2005. The 2b protein as a minor structural component of PRRSV. Virus Res[J]. 114: 177–181
Xiao Z, Batista L, Dee S, et al. 2004. The level of virus-specific T-cell and macrophage recruitment in porcine reproductive and respiratory syndrome virus infection in pigs is independent of virus load. Virol[J]. 78: 5923–5933
Xin K Q, Hamajima K, Sasaki S, et al. 1999. IL-15 expressing plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine. Vaccine[J]. 17 (728): 858-866
Xue Q, Zhao Y G, Zhou Y J, et al. 2004. Immune responses of swine following DNAimmunization with plasmids encoding porcine reproductive and respiratory syndrome virus ORFs 5 and 7, and porcine IL-2 and IFN-gamma. Veterinary Immunology and Immunopathology[J]. 102: 291–298
Yan-Jun Zhou, Tong-Qing An, Yun-Xia He, et al. 2006. Antigenic structure analysis of glycosylated protein 3 of porcine reproductive and respiratory syndrome virus. Virus Research[J]. 118: 98-104
Yin J, Dai A, Kutzler M A, et al. 2008. Sustained suppression of SHIV 89.6P replication inmacaques by vaccine-induced CD8+ memory T cells. AIDS[J]. 22: 1739–1748
Yoon I J, Joo H S, Christianson W T, et al. 1992. An indirect fluorescent antibody test for the detection of antibody to swine infertility and respiratory syndrome virus in swine sera. Veterinary Diagnostic Investigation[J]. 4: 144–147
Yoon I J, Joo H S, Goyal S M, et al. 1994. A modified serum neutralization test for the detection of antibody to porcine reproductive and respiratory syndrome virus in swine sera. Veterinary Diagnostic Investigation[J]. 6: 289–292
Yoon K J, Wv L L, Zimmerman J J, et al. 1996. Antibody-dependent enhancement (ADE) of porcine reproduction and respiratory syndrome virus (PRRSV) infection in pigs. Viral Immunol[J]. 9: 51-63
Yoon K J, Wu L L, Zimmerman J J, et al. 1997. Field isolation of porcine reproductive and respiratory syndrome virus vary in their susceptibility to antibody dependent enhancement (ADE) of infection. Vet Microbiol[J]. 55: 277-287
Yoshida S, Kashiwamura S I, Hosoya Y, et al. 2000. Direct immunization of malaria DNA vaccine into the liver by gene gun protects against lethal challenge of Plasmodium berghei sporozoite. Biochem Biophys Res Commun[J]. 271 (1): 107-115
Zhu Y, Si J, Ham D A, et al. 2002. The protective immunity produced in infected C57BL/6 mice of a DNA vaccine encoding Schistosoma japonicum Chinese strain triosephosphate isomerase. Southeast Asian J Trop Med Public Hlth[J]. 33 (2): 207-213
Zimmerman J J, Yoon K J, Wills R W, et al. 1997. General overview of PRRSV: a perspective from the United Stats. Vet Microbiol[J]. 55: 187-196
Zuckermann F A, Garcia EA, Luque I D, et al. 2007. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologicresponse, frequency of gamma-IFN producing cells and viro-logical parameters of protection upon challenge. Vet Microbiol[J]. 123 (1-3): 69-85
蔡雪晖,柴文君,翁长江. 2000.猪繁殖与呼吸综合症及其在我国的现状与对策.中国预防兽医学报[J]. 22: 202-205
陈创夫,余兴龙,马正海等. 2002.猪瘟基因疫苗在小鼠肌肉中的动态分布表达.畜牧兽医学报[J]. 33(3): 250-284
豆文波. 2005.猪繁殖与呼吸综合症病毒ORF5基因疫苗在小鼠体内动态分布与表达[D]. 绵阳:四川农业大学.研究生学位论文
樊福好. 2005.关于蓝耳病免疫的是是非非.畜禽业[J].(6): 6-9
房文亮,王永祥,金玉怀等. 2003. IL-15基因真核表达质粒的构建及其对CVB3 VP1基因疫苗的免疫增强作用.河北医科大学学报[J]. 24(3): 129-132
高云英,贺玉胜,刘秀琴等. 2002.猪繁殖与呼吸综合症研究进展.甘肃农业大学学报[J]. 37(6): 139-144
郭宝清,陈章水,刘文兴. 1996.从疑似PRRSV流产胎儿分离PRRSV的研究.中国畜禽传染病[J]. 2: 1-4
郭海龙. 2002.猪繁殖与呼吸综合征病毒感染猪体内细胞因子与病毒的定量检测[D].北京:中国农业科学院.硕士研究生学位论文
韩国全,郭万柱,孙志勇. 2008.猪霍乱沙门菌SC500运载TGEV S与猪IL-15融合基因疫苗的稳定性及免疫安全性.中国兽医科学. 38(10): 871-877
韩国全,郭万柱,王印等. 2009.内江猪IL-15基因的表达与免疫增强作用研究.中国兽医科学[J]. 39(06): 543-549
和晶亮. 2007. DNA疫苗的相关研究进展[J].动物医学进展. 28(增): 44-47
胡慧琼. 2006.四川山地乌骨鸡IL-2、15、18、IFN-γ基因克隆测序及分子佐剂效应研究[D].绵阳:四川农业大学.博士研究生学位论文
姜平. 2002.猪繁殖与呼吸综合征病毒研究新进展.丁壮,万遂如,金宁一,等.猪的重要传染病防治研究新成果. 2002.重庆:中国畜牧兽医学会家畜传染病学分会[J]. 84-88
江云波,方六荣,肖少波. 2007.猪白细胞介素15基因的克隆及在大肠杆菌中的表达.畜牧兽医学报[J]. 38(8): 841-845
J萨姆布鲁克, E F弗里奇, T曼尼阿蒂斯. 1996.分子克隆实验指南[M].第2版,北京: 北京科学出版社, 775-776
金伯泉. 2001.细胞和分子免疫学[M].北京:科学出版社. 131-239
金苗苗,沈国顺,张敏等. 2007.猪繁殖与呼吸综合征疫苗的研究进展.黑龙江畜牧兽医[J]. 06: 17-18
李成,李六金,谷守林. 2001.猪繁殖与呼吸综合症病毒形态学特征.畜牧兽医学报[J]. 32(6): 563-567
李华,杨汉春,许勇钢等. 2001.猪繁殖与呼吸综合征病毒感染仔猪淋巴细胞亚群的动态.兽医免疫学杂志[J]. 17(4): 208-211
刘芳,汪铭书,程安春等. 2005.人工感染PRRSV仔猪肺和子宫细胞凋亡的电镜观察.中国兽医科技[J]. 35(5): 327-332
刘光清,蔡雪晖,仇华吉等. 2001.猪繁殖与呼吸综合征的研究进展.中国预防兽医学报[J]. 23(1): 72-76
刘书亮,王红宁. 2000. PRRS的病原学和免疫学研究进展.四川畜牧兽医[J]. 27(7): 79-83
刘伍梅,汪铭书,程安春. 2005. DNA Ladder和ELISA联合检测PRRSV诱导Marc145细胞凋亡动态变化规律的研究.四川农业大学学报[J]. 23(1): 95-98
骆爱芳,郭万柱,宋振辉等. 2007.猪白细胞介素-15基因的克隆及生物信息学分析.中国畜牧兽医[J]. 34(10): 37-40
磨美兰. 2005. PRRSV感染对猪肺泡巨噬细胞外源性抗原加工递呈功能的影响[D].北京:中国农业大学.博士研究生学位论文
仇华吉,童光志. 2000.猪繁殖与呼吸综合症[M].吉林:科学技术出版社
孙欣,高顺强. 2007. IL-15表达质粒联合HPV基因疫苗诱导细胞免疫应答的实验研究.中国艾滋病性病[J]. 13(5): 417-419
田志军. 2005.表达PRRSV GP5蛋白的重组伪狂犬病毒的构建及其免疫效力的研究[D]. 哈尔滨:东北农业大学.博士研究生毕业论文
许立华,王玲,刘华雷. 2004.猪繁殖与呼吸综合征病毒分子生物学研究进展.宁夏农学院学报[J]. 25(2): 71-75
汪铭书,程安春,刘芳等. 2006.仔猪人工感染猪繁殖与呼吸综合征病毒后宿主细胞凋亡动态变化规律的研究.病毒学报[J]. 22(5): 385-390
温建新,李俊,周顺. 2008.含CpG序列PRRSV ORF5基因真核质粒构建及其免疫原性的研究.中国农业科学[J]. 41(5): 1503-1510
希尼尼根. 2004.猪呼吸与繁殖综合症病毒ORF5核酸疫苗的研究[D].绵阳:四川农业大学.博士研究生学位论文
杨春艳,苏先狮,李曼妮. 2004.白细胞介素IL-15重组体对HBsAg核酸疫苗的免疫佐剂作用.中华肝脏病杂志[J]. 12(12): 758-759
杨克礼,梁望旺,伍锐. 2009.母猪接种PRRS疫苗预防PRRSV垂直传播的效果.湖北农业科学[J]. (48)12: 3092-3094
殷震,刘景华. 1997.动物病毒学[M].第二版.北京:科学出版社
于在江,马学恩,周建华. 2007.切胶纯化表达蛋白包涵体的可行性分析.生物技术[J]. 3: 46-48
张成裕. 2004.免疫增强剂在动物医学上的研究进展及应用.福建畜牧兽医[J]. 26(增): 61-63
张晓梅,杨汉春,李华等. 1999.猪繁殖与呼吸综合征病毒实验感染SPF猪外周血单核细胞和肺泡巨噬细胞早期凋亡细胞的观察.中国兽医杂志[J]. 25(11): 11-13
周艳君,仇华吉,童光志. 2000.猪生殖-呼吸综合症病毒研究进展.中国预防兽医学报[J]. 2(3): 12-18
周艳君,仇华吉,王云峰等. 2000.应用杆状病毒系统高效表达猪繁殖与呼吸道综合症病毒GP5基因.中国预防兽医学报[J]. 22(4): 278 - 280
Ana C, David R G, Louis C G, et al. 1997. Molecular cloning of cDNA encoding porcine interleukin 15. Gene[J]. 195: 337-339
Albina E. 1997. Epidemiology of porcine and respiratory syndrome (PRRS): an overview. Vet Microbiol[J]. 55: 309-316
Albina, E, Carrat C, Charley B. 1998. Interferon-αresponse to swine arterivirus (PoAV), the porcine reproductive and respiratory syndrome virus. Journal of Interferon and Cytokine Research [J]. 18: 485–490
Allende R, Lewis TL, Lu Z, et al. 1999. North American and European porcine reproductive and respiratory syndrome viruses differ in non- structural protein coding regions. Gen Virol[J]. 80: 307-315
Asai T, Mori M, Okada M, et al. 1999. Elevated serum haptoglobin in pigs infected with porcine reproductive and respiratory syndrome virus. Veterinary Immunology and Immunopathology[J]. 70: 143–148
Aucoutorier J, Dupuis L, Ganne V. 2001. Adjuvants designed for veterinary and human vaccines. Vaccine[J]. 19 (17-19): 2666-2672
Aurora Fernández, Paloma Suárez, JoséMaría Castro, et al. 2002. Characterization of regions in the GP5 protein of porcine reproductive and respiratory syndrome virus required to induce apoptotic cell death. Virus Research[J]. 2 (83): 103-118
Balasuriya U B, MacLachlan N J. 2004. The immune response to equine arteritis virus: potential lessons for other arteriviruses. Vet Immunol Immunopathol[J]. 102: 107–129
Barfoed AM, Blixenkrone-Moller M, Jensen MH, Botner A, et al. 2004. DNA vaccination of pigs with open reading frame 1-7 of PRRS virus. Vaccine[J]. 22 (27-28): 28-41
Barry S, Peters, Walter Jaoko, et al. 2006. Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA)with and without DNA priming: Effects of dosage and route on safety and immunogenicity. Vaccine[J]. 25 (11): 2120-2127
Bastos RG, Dellagostin OA, Barletta RG, et al. 2004. Immune responses of pigs inoculated with Mycobacterium bovis BCG expressing atruncatedform of GP5 and M protein of porcine reproductive and respiratory syndrome virus. Vaccine[J]. 22 (4): 67–74
Bautista EM, Molitor TW. 1997. T cell response to the structural polypeptides of porcine reproductive and respiratory syndrome virus. Arch Virol[J]. 144: 117–1134
Bautista E M, Molitor T W. 1997. Cell-mediated immunity to porcine reproductive and respiratory syndrome virus in swine. Viral Immunology[J]. 10: 83–94
Bautista E M, Molitor T W. 1999. IFN-gamma inhibits porcine reproductive and respiratory syndrome virus replication in macrophages. Arch Virol[J]. 144 (6): 1191-200
Becker T C, Wherry E J, Boone D, et al. 2002. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8+ T cells. Exp Med[J]. 195: 1541–1548
Benfield D A, Nelson E, Collins J E, et al. 1992. Characterization of swine infertility and respiratory syndrome (SIRS) virus (isolate ATCC VR-2332). Vet Diagn Invest[J]. 4: 127–133
Benson J E. 2002. Functional properties of the predicted helicase of porcine reproductive and respiratory syndrome virus. Virol[J]. 19 (1): 235-241
Bilodeau R, Dea S, Martineau G P, et al. 1991. Porcine reproductive and respiratory syndrome in Quebec. Vet Rec[J]. 129: 102-103
Blaha T. 2000. The“colorful”epidemiology of PRRS. Vet Res[J]. 31 (1): 77-83
Bastos RG, Dellagostin O A, Barletta R G, et al. 2004. Immune response of pigs inoculated with Mycobacterium bovis BCG expressing a truncated form of GP5 and M protein reproductive and respiratory syndrome virus. Vaccine[J]. 22 (3/4): 467-474
Buddaert W, Van Reeth K, Pensaert M. 1998. In vivo and in vitro interferon (IFN) studies with the porcine reproductive and respiratory syndrome virus (PRRSV). Advances in Experimental Medicine and Biology[J]. 440: 461–467
Brievly I, Diggard P, Inglis S C. 1989. Characterization of an efficient Coronavirus ribosomal frameshifting signal: requirement for an RNA Pseudoknot. Cell[J]. 57: 537-547
Bruin M GM, SamsomJ N. 2000. Effects of a porcine reproductive and respiratory syndrome virus infection on the development of the immune response against pseudorabies virus. Veterinary Immunology and Immunopathology[J]. 76: 125-135
Cafruny W A, Bradley S E, Rowland R R. 1999. Regulation of immune complexes during infection of mice with lactate dehydrogenase-elevating virus: studies with interferon-gamma gene knockout and tolerant mice. Viral Immunol[J]. 12: 163–173
Cancel-Tirado SM, Evans RB, Yoon KJ. 2004. Monoclonal antibody analysis of porcine reproductive and respiratory syndrome virus epitopes associated with antibody-dependent enhancement and neutralization of virusinfection. Vet Immunol Immunopatho[J]. l102 (3): 249–262
Cavanaugh D. 1997. Nidovirales: a new order comprising Coronaviridae and Arteriviridae. Arch Vitol[J]. 142: 629-633
Charerntantanakul W, Platt R, Roth J A. 2006. Effects of porcine reproductive and respiratory syndrome virus-infected antigen-presenting cells on T cell activation and antiviral cytokine production. Viral Immunology[J]. 19: 646–661
Chehimi J, Marshall J D, Salvucci O, et al. 1997. IL-15 enhances immune functions during HIV infection. Immunol[J]. 158: 5978–5987
ChunS, DaheshiaM, LeeS, et al. 1999. Distribution fate and mechanism of immune modulation following mucosal delivery of plasmid DNA encoding IL-10. Irnrnunol[J]. 163 (5): 2393
Conzelmann K K, Visser N, Van Woensel P, et al. 1993. Molecular characterization of porcine reproductive and respiratory disease virus, a member of the arterivirus group. Virology[J]. 193: 329-339
Collins J E, Benfield D A, Christianson W T, et al. 1992. Isolation of swine infertility and respiratory syndrome virus (isolate ATCC VR-2332) in North America and experimental reproduction of the disease in gnotobiotic pigs. Vet Diagn Invest[J]. 4: 117–126
Coutelier J P, Van Snick J. 1988. Neautralization and sensitization of lactate dehydrogenase-elevating virus with monoclonal antibodies. Gen Virol[J]. 69: 2097-2100
Cox J C, Coulter A R. 1997. Adjuvants-a classification and review of their modes of action. Vaccine[J]. 15: 248
Christopher-Hennings J, Nelson E A, Nelson J K, et al. 1997. Effects of a modified-live virusvaccine against porcine reproductive and respiratory syndrome in boars. Vet Res[J]. 58: 40–45
de Limaa M, Pattnaika AK, Flores EF, et al. 2006. Serologic marker candidates identified among B-cell linear epitopes of Nsp2 and structural proteins of a North American strain of porcine reproductive and respiratory syndrome virus. Virology[J]. 353 (2): 410–421
Dea S, Gagonon C A, Mardassi H, et al. 1996. Antigenic variability among North American and European strains of porcine reproductive and respiratory syndrome virus as defined by monoclonal antibodies to the matrix protein. Clin Microbiol[J]. 34: 1488-1493
Dea S, Gagnon C A, Mardassi H, et al. 2000. Current knowledge on the structural proteins of porcine reproduetive and respiratory syndrome (PRRS) virus: comparion of the North American and European isolates. Arch Virol[J]. 145 (4): 659-688
de Lima M, Pattnaik A K, Flores E F, et al. 2006. Serologic marker candidates identified among B-cell linear epitopes of Nsp2 and structural proteins of a North American strain of porcine reproductive and respiratory syndrome virus. Virology[J]. 30: 410–421
Delputte P L, Meerts P, Costers S, et al. 2004. Effect of virus-specific antibodies on attachment, internalization and infection of porcine reproductive and respiratory syndrome virus in primary macrophages. Veterinary Immunology and Immunopathology[J]. 102: 179–188
de Vries A A F, Post S M, Raamsman M J B, et al. 1995. The two major envelope proteins of equine arteritis virus associate into disulfide-linked heterodimers. Virol[J]. 69: 4668-4674
Diaz I, Darwich L, Pappaterra G, et al. 2005. Immune responses of pigs after experimental infection with a European strain of Porcine reproductive and respiratory syndrome virus. Gen. Virol[J]. 86: 1943–1951
Diaz I, Darwich L, Pappaterra G, et al. 2006. Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs. Virology[J]. 351: 249–259
E Mateu, I Diaz. 2008. The challenge of PRRS immunology. Veterinary[J]. 177: 345–351
Fang L R, Jiang Y B, Xiao S B, et al. 2006. Enhanced immunogenicity of the modified GP5 of porcine reproductive and respiratory syndrome virus. Virus Genes[J]. 32 (1): 5-11
Fernandez A, Suarez P, Castro J M, et al. 2002. Characterization of regions in the GP5 protein of porcine reproductive and respiratory syndrome virus required to induce apoptotic cell death. Virus Res[J]. (83): 103-118
Foss D L, Zilliox M J, Meier W, et al. 2002. Adjuvant danger signals increase the immune response to porcine reproductive and respiratory syndrome virus. Viral Immuno[J]. l15 (4): 557-66
Gagnon C A, Lachapelle G, Langelier Y, et al. 2003. Adenoviral expressed GP5 of porcine reproductive and respiratory syndrome virus differs in its cellular maturation from the authentic viral protein but maintains known biological functions. Arch Virol[J]. 148: 951-972
Grabstein K H, Eisenman J, Shanebeck K, et al. 1994. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science[J]. 264: 965-968
Hong-Xiang Sun, Hui Wang, Hai-shun Xu, et al. 2009. Novel polysaccharide adjuvant from the roots of Actinidia eriantha with dual Th1 and Th2 potentiating activity. Vaccine[J]. 27: 3984–3991
Huang T S, Jong M H, Tu W J, et al. 2000. Differentiation of Taiwan porcine reproductive and respiratory syndrome virus isolates by RT-PCR amplification. Exp Rep NIAH[J]. 36: 23–28
I Díaz, L Darwich, G Pappaterra, et al. 2006. Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs. Virology[J]. 351: 249–259
Jiang W, Jiang P, Li Y, et al. 2006. Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice. Vet Immunol Immunopathol[J]. 113: 169–180
Jiangmei Yin, Anlan Dai, Dominick J, et al. 2009. High dose of plasmid IL-15 inhibits immune responses in an influenza non-human primates immunogenicity model. Virology[J]. 393: 49–55
Jiang Y B, Fang L R, Xiao S B, et al. 2007. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus. Vaccine[J]. 25: 547–60
Jinyan Liu, Michael Hellerstein, Michael McDonnel, et al. 2007. Dose–response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost. Vaccine[J]. 25: 2951–2958
Juas E R, Inaba Y, Kolone M, et al. 1996. Hemagglutination with PRRSV. Veterinary Medical Science[J]. 58 (6): 521-527
Joshua S, Ellingson, Yue Wang, et al. 2005. Vaccine efficacy of porcine reproductive and respiratory syndrome virus chimeras. Vaccine[J]. 108: 98-109
Kensil C R, Wu J-Y, Soltysik S. 1995. Structural and immunological characterization of the vaccine adjuvant QS-21. Vaccine design: the subunit and adjuvant approach. New York[J]. PlenumPress: 525–541
Keffaber K K. 1989. Reproductive failure of unknown etiology. Am Assoc Swine Pract Newsl[J]. 1: 1-19
Kheyar A, Jabrane A, Zhu C, et al. 2005. Altern ative codon usage of PRRS virus ORF5 gene increases eukaryotic expression of GP5 glycoprotein and improves immune response in challengedpigs. Vaccine[J]. 23: 4016–4022
Kim JJ, Ayyavoo V, Bagarazzi ML, et al. 1997. In vivo engineering of a cellular immune response by coadministration of IL-12 expressin vector with a DNA immunogen. Immunol[J]. 158 (2): 816-826
Kim J J, Trivedi N N, Nottingham L K, et al. 1998. Modulationof amplitude and direction of in vivo immune responses by coadministration of cytokine gene expression cassettes with DNA immunogens. Immunol[J]. 28 (3): 1089-1103
Kim J J, Simbiri KA, Sin JI, et al. 1999. Cytokine molecular adjuvants modulate immune responses induced by DNA vaccine constructs for HIV-1 and SIV. InterferonCytokineRes[J]. 19: 77
Kim J J, Yang J S, Manson K H, et al. 2001. Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvant. Vaccine[J]. 19: 2496
Kim S H, ChoD, Kim T S. 2001. Induction of in vivo resistance to Mycobacterium avium infection by intramuscular injection with DNA encoding interleukin-18. Immunology[J]. 102: 234
Kozak M. 1987. An analysis of 5-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res[J]. 15 (20): 8125-8140
Ku C C, Murakami M, Sakamoto A,et al. 2000. Control of homeostasis of CD8+memory T cells by opposing cytokines. Science[J]. 288: 655–678
Kutzler M A, Robinson T M, Chattergoon M A, et al. 2005. Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8+ T cells that are partially independent of CD4+ T cell help. Immunol[J]. 175: 112–123
Kwang J, Zuckermann F, Ross G. 1999. Antibody and cel llar Immune responses of swine following immunization with plasmid DNA encoding the PRRS virus ORFs4, 5, 6 and 7. Veterinary Science[J]. 67: 199-201
Labarque G G, Nauwynck H J, van Reeth K, et al. 2001. Apoptosis in the lungs of pigs during an inoculation with a European strain of porcine reproductive and respiratory syndrome virus. Adv Exp Med Biol[J]. 494: 691-697
Labarque G, Van Gucht S, VanReeth K, et al. 2003. Respiratory tract protection upon challenge of pigs vaccinated with attenuated porcine reproductive and respiratory syndrome virus vaccines. Vet Microbiol[J]. 95: 187–197
Labarque G, Van Gucht S, Nauwynck H, et al. 2003. Apoptosis in the lungs of pigs inoculated with porcine reproductive and respiratory syndrome virus and associations with the production of apoptogenic cytokines. Vet Res[J]. 34 (3): 249-260
Labarque G, Reeth K V, Nauwynck H, et al. 2004. Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy. Vaccine[J]. 22: 4183–4190
Lager K M, Mengeling W L, Brockmeier S L. 1999. Evaluation of protective immunity in gilts inoculated with the NADC-8 isolate of porcine reproductive and respiratory syndrome virus (PRRSV) and challenge-exposed with an antigenically distinct PRRSV isolate. American Journal of Veterinary Research[J]. 60: 1022–1027
Lagging L M, Meyer K, Hotf D, et al. 1995. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. Virol[J]. 69 (9): 5859-5863
Lee S M, Schommer S K, Kleiboeker S B. 2004. Porcine reproductive and respiratory syndrome virus field isolates differ in in vitro interferon phenotypes. Veterinary Immunology and Immunopathology[J]. 102: 217–231
Lee S M, Kleiboeker S B. 2005. Porcine arterivirus activates the NF-k B pathway through Ik B degradation. Virology[J]. 342: 47–59
Loemba H D, Mounir S, Mardassi H, et al. 1996. Kinetics of humoral immune response to the major structural proteins of the porcine reproductive and respiratory syndrome virus. Archives of Virology[J]. 141: 751–761
Lopez Fuertes L, Domenech N, Alvarez B, et al. 1999. Analysis of cellular immune response in pigs recovered from porcine respiratory and reproductive syndrome infection. Virus Research[J].64: 33–42
Lopez O J, Osorio F A. 2004. Role of neutralizing antibodies in PRRSV protective immunity. Vet Immunol Immunopathol[J]. 102: 155–163
Lopez O J, Oliveira M F, Garcia E A, et al. 2007. Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent. Clinical and Vaccine Immunology[J]. 14: 269–275
Lovell D. 2004. Biologic agents for the treatment of juvenile rheumatoid arthritis: current status. Paediatr Drugs[J]. 6 (3): 137-146
Luxembourg B and Lindhoff-Last E. 2007. Genomic diagnosis of thrombophilia in women: clinical relevance H mostaseologie[J]. 27: 22–31
Mardassi H, Athanassious R, Mfounir S, et al. 1994. Porcine reproductive and respiratory syndrome virus: morphological, biochemical and serological characteristics of Quebec isolates associated with acute and chronic outbreaks of porcine reproductive and respiratory syndrome. Can J Vet Res[J]. 58: 55-64
Mardassi H, Massie B, Dea S. 1996. Intracellular synthesis, processing, and transport of proteins encoded by ORFs 5 to 7 of porcine reproductive and respiratory syndrome virus. Virology[J]. 221: 98-112
Mariela Scortti, Cinta Prieto, Francisco J, et al. 2006. Effects of two commercial European modified-live vaccines against porcine reproductive and respiratory syndrome viruses in pregnant gilts. Veterinary[J]. 172: 506-514
Marshall J D, Fearon K L, Higgins D, et al. 2005. Superior activity of the type C class of ISS in vitro and in vivo across multiple species. DNA Cell Biol[J]. 24: 63–72
Meier W A, Galeota J, Osorio F A, et al. 2003. Gradual development of the interferon-gamma response of swine to porcine reproductive and respiratory syndrome virus infection or vaccination. Virology[J]. 309: 18–31
Mengeling W L, Lager K M, Vorwald A C. 1999. Safety and efficacy of vaccination of pregnant gilts against porcine reproductive and respiratory syndrome. Vet Res[J]. 60: 796–801
Mengeling W L, Lager K M, Vorwald A C, et al. 2003a. Comparative safety and efficacy of attenuated single-strain and multi-strain vaccines for porcine reproductive and respiratory syndromeVet. Microbiol[J]. 93: 25–38
Mengeling W L, Lager K M, Vorwald A C, et al. 2003b. Strain specificity of the immune response of pigs following vaccination with various strains of porcine reproductive and respiratory syndrome virus. Vet Microbiol[J]. 93: 13–24
Meng X J, Paul P S, Halbur P G. 1994. Molecular cloning and nucleotide sequencing of the 3’terminal genomic RNA of porcine reproductive and respiratory syndrome virus. Gen V irol[J]. 75: 1795-1801
Meulenberg J J, Hulst M M, De Meijer E J, et al. 1993a. Lelystad virus, the caustive agent of porcine epidemic abortion and respiratory syndrome (PEARS), is related to LDV and EAV. V irology[J]. 192: 62-72
Meulenberg J J, Besten A, De kluyver, et al. 1995. Characterization of protein encoded byORFs 2 to 7 of lelystad virus. Virology[J]. 206: 155-163
Meulenberg J J M, Petersen-den Besten A. 1996. Identification and characterization of a sixth structural protein of Lelystad Virus: the glycoprotein GP2 encoded by ORF2 is incorporated in virus particle. Viroligy[J]. 225: 44-51
Meulenberg J J, Petersenden Besten A, deKluyver E, et al. 1997. Molecular characterization of Lelystad virus. Veterinary Microbiology[J]. 55: 197–202
Meulenberg J J M. 2000. PRRSV, the Virus. Vet Res[J]. 31: 11-21
Min W, Lillehoj H S, Burnside J, et al. 2001. Adjuvant effects of IL-1beta, IL-2, IL-8, IL-15, IFN-alpha, IFN-gamma, TGF-beta 4 and lymphotactin on DNA vaccination against Eimeria acervulina. Vaccine[J]. 20 (122): 267-274
Molitor T W, Bautista E M, Chli C S. 1997. Immunity to PRRSV: Double-edged sword. Vet Mocrobio[J]. 55: 265-276
Mueller Y M, Do D H, Altork S R, et al. 2008. IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses. Immunol[J]. 180: 350–360
Murtaugh M P, Wlam M R, Kakach L T. 1995. Comparison of the structural protein coding sequences of the VR-2332 and Lelystad virus strains of the PRRS virus. Arch Virol[J]. 140: 1451-1460
Nelsen C J, Murtaugh M P, Faaberg K S. 1999. Porcine reproductive and respiratory syndrome virus comparison: Divergent evolution on two continents. Virol[J]. 73: 270-280
Nielson R and Botner A. 1997. Hematologieal and irnrnunologieal Parameters of 4.5-month old pigs infeeted with PRRS virus. Veterinary Microbiology[J]. 55: 289-294
Nelson E A, Christopher-Hennings J, Drew T, et al. 1993. Differentiation of US and European isolates of porcine reproductive and respiratory syndrome virus by monoclonal antibodies. Clin Microbiol[J]. 31: 3184–3189
Nelson E A, Christopher-Hennings J, Benfield D A. 1994. Serum immune responses to the proteins of porcine reproductive and respiratory syndrome (PRRS) virus. Journal of Veterinary Diagnostic Investigation[J]. 6: 410–415
Norman J A, Hobart P. 1997. Development of improved vectors for DNA-based immunization and other gene therapy applications. Vaccine[J]. 15 (8): 801-803
Oleksiewicz M B, Nielsen J. 1999. Effect of porcine reproductive and respiratory syndrome virus (PRRSV) on alveolar lung macrophage survival and function. Vet Microbiol[J]. 66: 15–27
Oleksiewicz M B, Botner A, Toft P, et al. 2001. Epitope mapping porcine reproductive and respiratorysyndrome virus by phage display: the nsp2 fragment of the replicase polyprotein contains a cluster of B-cell epitopes. Virology[J]. 75: 3277–3290
Onyekaba C O, Harty J T, Even C, Hu B G, et al. 1989. Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses. Virus Res[J]. 14: 297–315
Osorio F A, Galeota J A, Nelson E, et al. 2002. Passive transfer of virus-specific antibodiesconfers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity. Virology[J]. 302: 9–20
Ostrowski M, Galeota J A, Jar A M, et al. 2002. Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain. Virol[J]. 76 (9): 4241–4250
trick G, Pirzadeh B, Gagnon C A, et al. 1999. Seroneutralization of porcine reproductive and respiratory syndrome virus correlates with antibody response to the GP5 major envelope glycoprotein. Vet Diagn Invest[J]. 11: 20–26
Pejsak Z, Stadejek T, Markowska-Daniel I. 1997. Clinical signs and economic losses caused by porcine reproductive and respiratory syndrome virus in a large breeding farm. Vet Microbiol[J]. 55: 317–322
Pizadeh B, Dea S. 1997. Monoclonal antibodies to ORF5 product of porcine reproductive and respiratory syndrome virus define linear neutralizing determinants. Gen Virol[J]. 78: 1867-1873
Plagemann P G, Rowland R R, Faaberg K S. 2002. The primary neutralization epitope of porcine respiratory and reproductive syndrome virus strain VR-2332 is located in the middle of the GP5 ectodomain. Arch Virol[J]. 147: 2327–2347.
Plagemann P G. 2004. GP5 ectodomain epitope of porcine reproductive and respiratory syndrome virus, strain Lelystad virus.Virus Res[J]. 102: 225–230
Plana Duran J, liment I, Sarraseca J, et al. 1997. Baculovrius expression of proteins of porcine reproductive and respiratory syndrome virus strainOlot/91 involvement of ORF3 and ORF5 proteins in protection. Virus Genes[J]. 14: 19–29
Plana-Duran J, Bastons M, Urniza A, et al. 1997. Efficacy of an inactivated vaccine for prevention of reproductive failure induced by porcine reproductive and respiratory syndrome virus. Vet Microbiol[J]. 55: 361–370
Planat Duran J, Bastons M, Urniza A, et al. 1997. Efficacy of an inactivated vaccine for prevention of reproductive failure induced by porcine reproductive and respiratory syndrome virus. Vet Microbiol[J]. 55 (14): 361-370
Pol J M A, Wagenaar F, Reus J E G. 1997. Comparative morphogenesis of three PRRS virus strains. Vet Microbiol[J]. 55: 203-208
Qiu H J, Tian Z J, Tong G Z, et al. 2005. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets. Vet Immunol Immunopathol[J]. 106: 309–319
Rakhmilevich A L, Jamssem K, Turner J, et al. 1997. Cytokine genetherapy of cancer using gene gun technology: superior antitum or activity of interleukin-12. Human Gene Therapy[J]. 8: 1303
Ribic R, Habjanec L, Brgles M, et al. 2009. Novel Mannosyl Derivatives of peptidoglycan monomer: Synthesis and biological evaluation of immunomodulatory properties. Bioorganic &Medicinal Chemistry[J]. 17: 6096-6105
Rowland R R, Robinson B, Stefanick J, et al. 2001. Inhibition of porcine reproductive and respiratory syndrome virus by interferon-gamma and recovery of virus replication with2-aminopurine. Arch Viro[J]. 146 (3): 539-555
Royaee A R, Husmann R J, Dawson H D, et al. 2004. Deciphering the involvement of innate immune factors in the development of the host response to PRRSV vaccination. Veterinary Immunology and Immunopathology[J]. 102: 199–216
San gkon O H, Berzofsky J A, Burke DS, et al. 2003. Coadministration of HIV vaccine vectors with vaccinia virusesexpressing IL-15 but not IL-2 induces long-lasting cellular immunity. PNAS[J]. 100: 3392-3397
Schijns V E. 2003. Mechanisms of vaccine adjuvant activity: initiation and regulation of immune responses by vaccine adjuvants. Vaccine[J]. 21: 829
Schirmbeck R, Melber K, Mertens T, et al. 1994. Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implications for the pathogenesis of HBV-induced hepatitis. Viro[J]. l68: 1418–1425
shimizu M, Yamada S. 1996. Change of lymphocyte populations in pigs infection with porcine reproductive and respiratory syndrome (PRRS) virus. Vet Immunol immunopathol[J]. 50: 19-27
Sin J I, Kim J J, Boyer J D, et al. 1999. In vivo modulation of vaccine induced immune responses towarda Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model. Viro1[J]. 73 (1): 501-509
Sirinarumitr T, Zhang Y, Kluge J P, et al. 1998. A pneumo-virulent United States isolate of porcine reproductive and respiratory syndrome virus induces apoptosis in bystander cells both in vitro and in vivo. Gen Viro[J]. l79: 2989–2995
Song K, Chang Y, Prudhomme G J. 2000. Regulation of T-helper-1versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and non viral cytokine gene transfer. GeneTherapy[J]. 7: 481
Suarez P, Diaz-Guerra M, Prieto C, et al. 1996. Open reading frame 5 of porcine reproductive and respiratory syndrome virus as a cause of virus-induced apoptosis. Virol[J]. 70 (5): 2876-2882
Suradhat S, Thanawongnuwech R, Poovorawan Y. 2003. Upregulation of IL-10 gene expression in porcine peripheral blood mononuclear cells by porcine reproductive and respiratory syndrome virus. General Virology[J]. 84: 453–459
Sur J H, Doster A R, Christian J S, et al. 1997. Porcine reproductive and respiratory syndrome virus replicates in testicular germ cells, alters spermatogenesis, and induces germ cell death by apoptosis. Virol[J]. 71 (12): 9170-9179
Takikawa N, Kobayashi S, Ide S, et al. 1996. Detection of antibodies against porcine reproductive and respiratory syndrome(PRRS)virus in swine sera by enzyme-linked immunosorbent assay. Veterinary Medical Science[J]. 58: 355–357
Tascon R E, Stavro pulos E, Lukacs K V, et al. 1998. Protection against Mycobacterum tuberculosis infection by CD8 T cells requires the production of gamma interferon IfectImmun[J]. 66: 830-834
Thanawongnuwech R, Thacker B, Halbur P, 2004. Increased production of proinflammatory cytokines following infection with porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae. Clinical and Diagnostic Laboratory Immunology[J]. 11: 901–908
Torremorrel M, Pijoan C, Janni K, et al. 1997. Airborne transmission of Actinobacillus pleuropneumoniae and porcine reproductive and respiratory syndrome virus in nursery pigs. Vet Res[J]. 58: 828–832
Yaeger M J, Prieve T, Collins J, et al. 1993. Evidence for the transmission of porcine reproductive and respiratory syndrome (PRRSV)virus in boar semen. Swine Hlth Prod[J]. 1: 5–9
Van Reeth K, Labarque G, Nauwynck H, et al. 1999. Differential production of proinflammatory cytokines in the pig lung during different respiratory virus infections: correlations with pathogenicity. Research in Veterinary Science[J]. 67: 47–52
Vezina S A, Loemba H, Fournier M, et al. 1996. Antibody production and blastogenic response in pigs experimentally infected with porcine reproductive and respiratory syndrome virus. Canadian Journal of Veterinary Research[J]. 60: 94–99
Voicu I L, Silim A, Morin M, et al. 1994. Interaction of porcine reproductive and respiratory syndrome virus with swine monocytes. Veterinary Record[J]. 134: 422–423
Wang C, Huang T S, Huang C C, et al. 2004. Characterization of porcine circovirus type 2 in Taiwan. Vet Med Sci[J]. 66: 469–475
Wang X, Eaton M, Mayer M, et al. 2007. Porcine reproductive and respiratory syndrome virus productively infects monocyte-derived dendritic cells and compromises their antigen-presenting ability. Archives of Virology[J]. 152: 289–303
Weiland E, Wieczorek-Krohmer M, Kohl D, et al. 1999. Monoclonal antibodies to the GP5 of porcine reproductive and respiratory syndrome virus are more effective in virus neutralization than monoclonal antibodies to the GP4. Vet Microbiol[J]. 66: 171-186
Wensvoort T, Terpstra C, Pol J, et al. 1991. Blue ear disease of pigs. Vet Rec[J]. 128: 574
Wensvoort G, deKluyver E P, Pol J M, et al. 1992. Lelystad virus, the cause of porcine epidemic abortion and respiratory syndrome: a review of mystery swine disease research at Lelystad. Vet Microbiol[J]. 33: 185–193
Wills R W, Zimmerman J J, Yoon K J, et al. 1997. Porcine reproductive and respiratory syndrome virus: routes of excretion. Vet Microbiol[J]. 57: 69–81
Wissink E H, vanWijk H A, Kroese M V, et al. 2003. The major envelope protein, GP5, of a European porcine reproductive and respiratory syndrome virus contains a neutralization epitope in its N-terminal ectodomain. Gen Virol[J]. 84: 1535–1543
Wolfgang W, Leitner Han Ying, Nicholas P. 1999. DNA and RNA-based vaccines: principles, progress and prospects. Vaccine[J]. 10 (18): 9-10
Wu W H, Fang Y, Rowland R R, et al. 2005. The 2b protein as a minor structural component of PRRSV. Virus Res[J]. 114: 177–181
Xiao Z, Batista L, Dee S, et al. 2004. The level of virus-specific T-cell and macrophage recruitment in porcine reproductive and respiratory syndrome virus infection in pigs is independent of virus load. Virol[J]. 78: 5923–5933
Xin K Q, Hamajima K, Sasaki S, et al. 1999. IL-15 expressing plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine. Vaccine[J]. 17 (728): 858-866
Xue Q, Zhao Y G, Zhou Y J, et al. 2004. Immune responses of swine following DNAimmunization with plasmids encoding porcine reproductive and respiratory syndrome virus ORFs 5 and 7, and porcine IL-2 and IFN-gamma. Veterinary Immunology and Immunopathology[J]. 102: 291–298
Yan-Jun Zhou, Tong-Qing An, Yun-Xia He, et al. 2006. Antigenic structure analysis of glycosylated protein 3 of porcine reproductive and respiratory syndrome virus. Virus Research[J]. 118: 98-104
Yin J, Dai A, Kutzler M A, et al. 2008. Sustained suppression of SHIV 89.6P replication inmacaques by vaccine-induced CD8+ memory T cells. AIDS[J]. 22: 1739–1748
Yoon I J, Joo H S, Christianson W T, et al. 1992. An indirect fluorescent antibody test for the detection of antibody to swine infertility and respiratory syndrome virus in swine sera. Veterinary Diagnostic Investigation[J]. 4: 144–147
Yoon I J, Joo H S, Goyal S M, et al. 1994. A modified serum neutralization test for the detection of antibody to porcine reproductive and respiratory syndrome virus in swine sera. Veterinary Diagnostic Investigation[J]. 6: 289–292
Yoon K J, Wv L L, Zimmerman J J, et al. 1996. Antibody-dependent enhancement (ADE) of porcine reproduction and respiratory syndrome virus (PRRSV) infection in pigs. Viral Immunol[J]. 9: 51-63
Yoon K J, Wu L L, Zimmerman J J, et al. 1997. Field isolation of porcine reproductive and respiratory syndrome virus vary in their susceptibility to antibody dependent enhancement (ADE) of infection. Vet Microbiol[J]. 55: 277-287
Yoshida S, Kashiwamura S I, Hosoya Y, et al. 2000. Direct immunization of malaria DNA vaccine into the liver by gene gun protects against lethal challenge of Plasmodium berghei sporozoite. Biochem Biophys Res Commun[J]. 271 (1): 107-115
Zhu Y, Si J, Ham D A, et al. 2002. The protective immunity produced in infected C57BL/6 mice of a DNA vaccine encoding Schistosoma japonicum Chinese strain triosephosphate isomerase. Southeast Asian J Trop Med Public Hlth[J]. 33 (2): 207-213
Zimmerman J J, Yoon K J, Wills R W, et al. 1997. General overview of PRRSV: a perspective from the United Stats. Vet Microbiol[J]. 55: 187-196
Zuckermann F A, Garcia EA, Luque I D, et al. 2007. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologicresponse, frequency of gamma-IFN producing cells and viro-logical parameters of protection upon challenge. Vet Microbiol[J]. 123 (1-3): 69-85